Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients With Implantable Cardioverter-Defibrillators
Chang, Ian C.Y., MD, Agamawi, Yusuf M., BS, Austin, Erin, MS, PhD, Adkisson, Wayne O., MD, Roukoz, Henri, MD, von Wald, Lisa N., NP, Sakaguchi, Scott, MD, Benditt, David G., MD, Chen, Lin Y., MBBS, MS
Published in The American journal of cardiology (15.11.2016)
Published in The American journal of cardiology (15.11.2016)
Get full text
Journal Article